AC Immune (ACIU) Stock Fundamentals & Financials

AC Immune is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Martin Zügel, with a market cap of $236.1M.

Market cap

$236.11M+6.7%

We’re still putting together AC Immune’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move AC Immune up the queue, and we’ll analyze its filings next.

Earnings

Q2 2026 report

August 5, 2026

Revenue$9.8MBeat by $245.5K EPS$0.03Beat by $0.13

Read the full report

Next report

Nov 3, 2026 (in 3 months)

Revenue estimate$249.7K

EPS estimate-$0.22

Profile

CountrySwitzerland

Listed2016

Employees161.0

CEOMartin Zügel

SectorHealthcare

IndustryBiotechnology

Websiteacimmune.com

FilingsSEC EDGAR